Sirona Biochem Corp.

Ordinary Shares International Reporting
Pink Current Information
Contact Info
  • 605-889 West Pender Street
  • Vancouver, BC V6C 3B2
  • Canada

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Latest Report Apr 30, 2014 Quarterly Report
Fiscal Year End 10/31
OTC Marketplace Pink Current
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: British Columbia, Canada
Year of Inc. 2009
Employees 13 a/o Aug 22, 2013
Company Officers/Contacts
Dr. Howard Verrico Founder, Interim CEO
Christopher Hopton CFO
Geraldine Deliencourt- Godefroy Chief Scientific Officer
Antonia Issa Corp. Commun.
Company Directors
Dr. Howard Verrico Chairman
Geraldine Deliencourt- Godefroy
Christopher Hopton
Dr. Alex Sandro Marazzi
David Moore
Michael Rogers
Chris Verrico
Service Providers
Accounting/Auditing Firm
Meyers Norris Penny, LLP
900- 50 Burnhamthorpe Road West
Sussex Centre
Mississauga, ONT, L5B3C2
Securities Counsel
Boughton Law Corporation
595 Burrard Street #700
Vancouver, BC, V7X 1S8
Investor Relations Firm

Not Available
SRBCF Security Details
Share Structure
Market Value1 $14,114,430 a/o Oct 20, 2017
Authorized Shares Unlimited a/o Oct 31, 2011
Outstanding Shares 120,636,155 a/o Jun 30, 2014
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders of Record Not Available
Non US Stock Exchange Listing
SBM - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 79,800 (34.57%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security